Strong FY2024 results with 6.3% revenue growth, 10.1% EBITDA growth, and improved ROIC, driven by digital efficiencies and strategic execution. Over ZAR 2 billion returned to shareholders, with continued investment in digital, sustainability, and patient-centered care initiatives.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.